TAKEDA PHARM CO (TKPHF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 26 91 sessions, October 14, 2025 to October 23, 2026
- Largest daily move
- +14.1% close of October 15, 2026
- 1-year change
- +41.9% closing prices, October 14, 2025 to October 23, 2026
- 1-month change
- +8.5% closing prices, September 21, 2026 to October 23, 2026
Company Description
TAKEDA PHARM CO (OTC: TKPHF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $65.8B.
TKPHF has gained 41.9% over the past year. The last closing price was $41.22.
For FY2025, TAKEDA PHARM CO reported revenue of $30.6B with net income of $720.0M and diluted earnings per share of $0.45. The company operates at a net profit margin of 2.4%.
This page collects what Stock Titan holds for TKPHF, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
TAKEDA PHARM CO (TKPHF) closed at $41.22 on October 23, 2026. Over the past 12 months, the price has gained 41.9%.
TKPHF Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
SEC Filings
TAKEDA PHARM CO has filed 10 recent SEC filings, including 5 Form 4, 4 Form 144, 1 Form 6-K. The most recent filing was submitted on September 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TKPHF SEC filings →
Financial Highlights
TAKEDA PHARM CO generated $30.6B in revenue in FY2025, retaining a 65.5% gross margin, operating income reached $2.3B (7.5% operating margin), and net income was $720.0M, reflecting a 2.4% net profit margin. Diluted earnings per share stood at $0.45. The company generated $7.1B in operating cash flow. The current ratio was 1.01, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in TAKEDA PHARM CO (TKPHF) currently stands at 2.7 million shares, up 19.6% from the previous reporting period, representing 0.2% of the float. Since October 2025, short interest has decreased by 25.3%.
Days to Cover History
Days to cover for TAKEDA PHARM CO (TKPHF) currently stands at 121.8 days, down 87.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 38.3%. Across the settlements charted above, it has ranged from 10.6 to 1000.0 days.
TKPHF Company Profile & Sector Positioning
TAKEDA PHARM CO (TKPHF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TKPHF often look at related companies in the same sector, including MERCK KGAA (MKKGY), SANDOZ GROUP AG (SDZNY), IPSEN SA (IPSEY), DAIICHI SANKYO (DSNKY), and HIKMA PHARMS PLC (HKMPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TKPHF's relative position within its industry.